Slashdot Mirror
FDA Designates MDMA As 'Breakthrough Therapy' For PTSD (futurism.com)
In what could lead to a faster path to pharmaceutical approval, the U.S. Food and Drug Administration (FDA) has designated methylenedioxymethamphetamine (MDMA) as a "breakthrough therapy" in the treatment of post-traumatic stress disorder (PTSD). Futurism reports: The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the FDA's ruling last week, revealing that they can now move forward on two of their upcoming "Phase 3" trials. The goal of these trials is to determine how effectively the drug can be used to treat those suffering from PTSD. The trials will include 200 to 300 participants, and the first trial will begin to accept subjects in 2018. The trials will be held in the U.S., Canada, and Israel, and MAPS plans to open talks with the European Medicines Agency in the hopes of expanding testing to include Europe. For now, the focus is on securing the funding they require. According to Science, the organization is still in the process of raising money for the trials, and thus far, they've only managed to secure $13 million, about half of their goal.
Previous MAPS trials exploring how well MDMA could treat PTSD have yielded favorable results, contributing to the FDA's aforementioned decision. In the association's Phase 2 trails, 107 people who had PTSD for an average of 17.8 years were treated using MDMA-assisted psychotherapy. After two months, 61 percent of the participants no longer suffered from PTSD. After a year, that number increased to 68 percent, according to the MAPS press release.
Previous MAPS trials exploring how well MDMA could treat PTSD have yielded favorable results, contributing to the FDA's aforementioned decision. In the association's Phase 2 trails, 107 people who had PTSD for an average of 17.8 years were treated using MDMA-assisted psychotherapy. After two months, 61 percent of the participants no longer suffered from PTSD. After a year, that number increased to 68 percent, according to the MAPS press release.
In the 70s it was used for exactly this purpose and with great success. Then it got banned. "Breakthrough", lol, morons.
"In the association’s Phase 2 trails, 107 people who had PTSD for an average of 17.8 years were treated using MDMA-assisted psychotherapy. After two months, 61 percent of the participants no longer suffered from PTSD. After a year, that number increased to 68 percent, according to the MAPS press release."
"we did a double blind test to see if it worked" seems like science to me.
What is unscientific about proposing a hypothesis and testing it?
They would have a hypothesis, observation and conclusion which may simply be "more research needed" that IS science. Science isn't the answer, it's the process.
https://www.merriam-webster.co...
It's not that often that a non-native speaker gets to teach a native speaker a new word, I guess.
We used to have a Bill of Rights. Now, with the rights gone, all we have left is the bill.
The topic under discussion is PTSD, not clinical depression (btw - it's not called clinical depression any more - it's now known as major depressive disorder, to better distinguish it from run-of-the-mill depression that everyone gets once in a while and that's completely normal).
PTSD is a form of anxiety disorder - a different kettle of fish. Sure, it's often accompanied by major depressive episodes, but it's important to understand that you're dealing with two different illnesses, and that curing PTSD won't necessarily cure MDD (especially since the brain is pretty plastic, and the more often you have an episode of major depression, the more likely you are to have another one).
"Transparent" is a shit show that trades on every stereotype going. A man in drag is NOT a transsexual.
The history of MDMA isn't one of patent abuse, but malfeasance by the DEA. The first MDMA synthesis patent was filed in 1912.
MDMA was put on schedule I by the DEA against the guidance of the medical community, who sued to have it rescheduled. After a judge ruled that it had valid medical uses and should be rescheduled, the DEA unilaterally declared that it has no medical uses again and banned it.
If you want a vision of the future, imagine a youtube comments section scrolling - forever.
Anyone not familiar with MAPS: Multidisciplinary Association for Psychedelic Studies should check them out and support them if possible. They have been at the forefront of supporting research and helping researchers navigate the complex legal/political terrain for decades. Highly recommended group.
-a.e.mossberg